CardioArt Technologies
Noninvasive Measurement of Hemodynamic Parameters
Company Overview
Snapshot
Founded in February 2005 by Eyal Karev, CardioArt Technologies operates with 1–10 employees. The company focuses on developing noninvasive technology for hemodynamic parameter measurement. In March 2020, CardioArt Technologies ceased to operate.
Business overview
CardioArt Technologies develops technology for the noninvasive measurement of various hemodynamic parameters, aiming to reduce risks associated with procedures like right heart catheterization. The company's initial product line was designed to treat patients with congestive heart failure. Operating within the Health Tech & Life Sciences sector, CardioArt Technologies serves the healthcare industry by providing diagnostic devices and solutions for healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is CardioArt Technologies' primary focus?
- CardioArt Technologies focuses on developing noninvasive technology for measuring hemodynamic parameters, with an initial product line aimed at treating patients with congestive heart failure.
- When was CardioArt Technologies founded?
- CardioArt Technologies was founded in February 2005.
- Who founded CardioArt Technologies?
- CardioArt Technologies was founded by Eyal Karev.
- What is the current status of CardioArt Technologies?
- CardioArt Technologies is currently non-active and ceased to operate in March 2020.